Search Reset
Query > English
WIPO Workforce 2022
December Edition
WIPO's workforce is the human capital of the Organization and its greatest asset. This brochure shows a detailed picture of staffing at WIPO in 2022.
Publication year: 2022
Madrid Yearly Review 2023
International Registration of Marks
Comprehensive facts, figures and analysis of the international registration of marks.
Publication year: 2023
Hague Yearly Review 2023
International Registration of Industrial Designs
Comprehensive facts, figures and analysis of the international registration of industrial designs.
COVID-19 vaccines and therapeutics
Insights into related patenting activity throughout the pandemic
Since the start of the COVID-19 pandemic there have been remarkable research and innovation efforts to fight the SARS-CoV-2 virus and the COVID-19 disease. This report provides observations based on a comprehensive review of the patenting activity that took place in the field of COVID-19 vaccines and therapeutics and builds on the insights discussed in the first WIPO COVID-19 Patent Landscape Report published in March 2022.
Protocol Relating to the Madrid Agreement Concerning the International Registration of Marks; Regulations; Administrative Instructions; Schedule of Fees.
The present publication contains the texts of the Protocol Relating to the Madrid Agreement Concerning the International Registration of Marks (hereinafter referred to as the “Protocol”) (1989), as amended in 2006 and in 2007, the Regulations under the Protocol Relating to the Madrid Agreement Concerning the International Registration of Marks, the Administrative Instructions for the Application of the Protocol and the Schedule of Fees.
WIPO IP Facts and Figures 2023
An overview of intellectual property activity based on the latest available year of complete statistics.
Intellectual Property and Technology Transfer for COVID-19 Vaccines: Assessment of the Record
Executive Summary
This Executive Summary concisely presents the results of an independent study commissioned by the World Intellectual Property Organization (WIPO)'s Global Challenges Division looking at the role played by intellectual property (IP) and technology transfer in the development, production and distribution of vaccines used to address the COVID-19 pandemic. The study uses a case-study approach to provide an in-depth analysis of some of the different approaches adopted by ten different global vaccine manufacturers, with respect to their funding, procurement, vaccine development and IP strategies (including licensing, technology transfer and access provisions). These experiences and lessons learnt provide practical insights to guide global policy-making on IP, health and access issues.
The World Intellectual Property Organization (WIPO)'s Global Challenges Division commissioned an independent study on the role played by intellectual property (IP) and technology transfer in the development, production and distribution of vaccines used to address the COVID-19 pandemic. The study uses a case-study approach to provide an in-depth analysis of some of the different approaches adopted by ten different global vaccine manufacturers, with respect to their funding, procurement, vaccine development and IP strategies (including licensing, technology transfer and access provisions). These experiences and lessons learnt provide practical insights to guide global policy-making on IP, health and access issues.
Intellectual Property and Genetic Resources
Background Brief - No. 10
This Brief introduces intellectual property issues related to genetic resources under discussion in WIPO.
The WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore
Background Brief - No. 2
This Brief provides background information on the WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore (IGC).